Thursday, 20 February 2020

Japan News

  • Free software creates largest neural simulation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: Researchers from the Riken HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology Graduate University in Japan and Forschungszentrum Jülich in Germ...Read more

  • Seegene and Eidia to bring MoDx tests to Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: Seegene, a leading developer of multiplexed molecular technologies and diagnostic tests, has entered into a collaboration agreement with Eidia, the in vitro diagnostics subsidiar...Read more

  • Reverse Medical announces alliance in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Singapore: Reverse Medical announced entering into a strategic partnership agreement with Century Medical (CMI), for distribution of the Reverse Medical products in Japan. CMI, a subsidiary...Read more

  • FDA accepts Astellas' NDA for organ rejection drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

    Singapore: Astellas Pharma, US, a US subsidiary of Tokyo-based Astellas Pharma, received US FDA acceptance for review of the company's New Drug Application (NDA) for tacrolimus extended re...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • Takeda drug Azilva launched in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

    Singapore: Takeda Pharmaceutical's Azilva (azilsartan) is now available for the treatment of hypertension in Japan. Discovered by Takeda, azilsartan is an angiotensin II receptor blocker (A...Read more

  • Japan approves Humira for Crohn's disease patients

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: Japan's Ministry of Health, Labor and Welfare has approved the use of Humira in induction and maintenance of clinical remission in patients with moderately to severely active Cro...Read more

  • Takeda asks judge to rule in its favor

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2013

    Singapore: Takeda Pharmaceuticals, US, highlighted that in the case against Jack Cooper (No CGC-12-518535) the jury ruled in favor of the plaintiffs and awarded a total of $6.5 million in d...Read more

  • Life Tech, Japanese firm to launch stem cell kit

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

    Singapore: Life Technologies has extended its collaborative agreement with Japanese firm DNAVec Corporation to launch CytoTune-iPS 2.0 Sendai Reprogramming Kit, the next-generation research...Read more

  • Telemedicine is revolutionizing healthcare access

    Japan |  Analysis | By BioSpectrum Bureau  | 1 Comment | 30 Nov, 2012

    Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution in providing specialty healthcare, improving access and reducing cos...Read more

  • Teva pregnancy 'preventor' gets FDA nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    Singapore: The US FDA has approved Teva Pharmaceutical's Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy. Quartette represents ext...Read more

  • Growth ahead for Japan's pharma, medtech

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

    Singapore: Japan's pharmaceutical market was estimated to be worth $89.1 billion in 2012 and is expected to reach approximately $104.5 billion by 2020 at a compound annual growth rate (CAGR...Read more

  • Evolva, Ajinomoto enter development deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

    Singapore: Evolva Holding SA entered into a collaboration agreement with Ajinomoto, Japan, for the joint development of novel fermentation production routes for a natural functional ingredi...Read more

  • Astellas, Sanwa launch hyperkalemia treatment

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jan, 2013

    Singapore: Tokyo-headquartered Astellas Pharma and Sanwa Kagaku Kenkyusho, based in Nagoya, Japan, have launched a hyperkalemia treatment Argamate 89.29 percent Granule 5.6g in Japan. Arga...Read more

  • Sanofi seeks approval for Lyxumia in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational once-daily GLP-1 receptor agonist, to the Ministry of Health, Labour ...Read more

  • Hitachi mRNA assay to target personalized medicine

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Hitachi Chemical has developed a novel mRNA quantitative assay called Hem(A)+ System that offers a wide range of applications in clinical biomarker discovery and molecular testi...Read more

  • Eisai to launch breast cancer drug in India

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel anti-cancer drug Eribulin, sold under the brand name of Halaven in Ind...Read more

  • Japan approves broader indication for Lyrica

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Pfizer Japan has received approval in Japan to replace the current indication of peripheral neuropathic pain for pain treatment Lyrica Capsules (pregabalin) with the new and broa...Read more